These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 122680)
1. Penicillamine types in the sclerodermas. Tio TH Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):78-9. PubMed ID: 122680 [No Abstract] [Full Text] [Related]
2. Treatment of systemic sclerosis. Wigley FM Curr Opin Rheumatol; 1992 Dec; 4(6):878-86. PubMed ID: 1457284 [TBL] [Abstract][Full Text] [Related]
3. Connective tissue changes in systemic sclerosis and the use of D-penicillamine. Jayson MI Agents Actions Suppl; 1979; (5):149-57. PubMed ID: 294132 [No Abstract] [Full Text] [Related]
4. Progressive systemic sclerosis and penicillamine. Rodnan GP J Rheumatol Suppl; 1981; 7():116-20. PubMed ID: 6939873 [TBL] [Abstract][Full Text] [Related]
5. [Sympatholytic effect of intra-arterial reserpine in sclerodermia and Raynaud's disease]. Acevedo A; Palacios JM; López R; Palma F Rev Med Chil; 1984 Jun; 112(6):553-8. PubMed ID: 6515168 [No Abstract] [Full Text] [Related]
6. Penicillamine for systemic sclerosis? Drug Ther Bull; 1974 Sep; 12(19):75-6. PubMed ID: 4469492 [No Abstract] [Full Text] [Related]
7. [Experience using d-penicillamine in systemic scleroderma]. Nemchinov EN; Krel' AA; Shekhter AB; Rashchupkina ZP Klin Med (Mosk); 1982 Jan; 60(1):77-82. PubMed ID: 7078046 [No Abstract] [Full Text] [Related]
8. [Penicillamine in the treatment of patients with systemic scleroderma]. Gandzha IM Vrach Delo; 1987 May; (5):66-7. PubMed ID: 3617690 [No Abstract] [Full Text] [Related]
12. [Penicillamine in the treatment of scleroderma]. Kobíková M; Stáva Z Cesk Dermatol; 1973 Dec; 48(6):408-10. PubMed ID: 4771784 [No Abstract] [Full Text] [Related]
13. [Treatment of progressive scleroderma with D-penicillamine (Metalcaptase)]. Böni A; Pavelka K; Kludas M Munch Med Wochenschr; 1969 Aug; 111(31):1580-4. PubMed ID: 5394493 [No Abstract] [Full Text] [Related]
14. [Therapeutic effect of d-penicillamine in scleroderma]. Bogdanikowa B; Rudy J; Bernacka K; Palka Z Pol Tyg Lek; 1973 Aug; 28(34):1317-20. PubMed ID: 4756401 [No Abstract] [Full Text] [Related]
15. Two years of penicillamine for progressive systemic sclerosis: a case report. Thomson J; Milne JA Postgrad Med J; 1974 Aug; 50 Suppl 2():36-8. PubMed ID: 4467175 [No Abstract] [Full Text] [Related]
17. [Effect of penicillin and D-penicillamine on beta-galactosidase activity in patients with progressive scleroderma]. Schulze E; Herrmann K; Haustein UF; Krusche U; Rothenburger I Dermatol Monatsschr; 1988; 174(11):661-6. PubMed ID: 3145222 [No Abstract] [Full Text] [Related]
18. Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment. Bluestone R; Grahame R; Holloway V; Holt PJ Ann Rheum Dis; 1970 Mar; 29(2):153-8. PubMed ID: 5427411 [No Abstract] [Full Text] [Related]
19. [Penicillamine in the treatment of scleroderma. Lathyrogenic drugs]. Szczepanski A Przegl Dermatol; 1971; 58(3):355-9. PubMed ID: 4944035 [No Abstract] [Full Text] [Related]
20. [Recent attempts at treatment of diffuse scleroderma]. Pavelka K Cas Lek Cesk; 1972; 111(10):221-3. PubMed ID: 5010871 [No Abstract] [Full Text] [Related] [Next] [New Search]